TSTL Tristel plc

425.00GBp+2.41%Mkt Cap: 222.08M $P/E: 26.56

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical De…

Key Statistics

Company
Market Cap222.08M USD
Enterprise Value204.66M USD
Revenue (TTM)53.84M USD
Gross Profit40.72M USD
Net Income (TTM)7.22M USD
Revenue/Share1.04 GBp
Last Price425.00 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees270
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)26.56
P/E (Forward)20.06
PEG—
EV/EBITDA16.44
EV/Revenue3.80
P/S3.98
P/B5.83
EPS (TTM)0.16
EPS (Forward)0.20
52W Range
350.0075% of range450.00
52W High450.00 GBp
52W Low350.00 GBp
Profitability
Gross Margin80.62%
Oper. Margin19.71%
EBITDA Margin23.12%
Profit Margin14.29%
ROE20.13%
ROA14.65%
Growth
Revenue Growth13.60%
Earnings Growth42.40%
Cash Flow & Leverage
Operating CF11.21M USD
CapEx (TTM)2.15M USD
FCF Margin14.30%
FCF Yield3.47%
Net Debt-8.11M USD
Net Debt/EBITDA-0.65
Balance Sheet
Debt/Equity0.18
Current Ratio4.13
Quick Ratio3.45
Book Value/Sh0.70 GBp
Cash/Share0.28 GBp
Dividends
Fwd Div Rate0.14 GBp
Trail. Div Rate0.14 GBp
Div. Yield3.46%
5Y Avg Yield2.40%
Payout Ratio87.44%
Ex-Div DateMar 19, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)475.18 GBp
Upside (mean)+11.8%
Target Range400.00 GBp – 560.00 GBp
400.00+11.8% to mean560.00
# Analysts6
Ownership
Shares Out.48.07M
Float46.08M
Insiders2.36%
Institutions47.57%
Technical
SMA 50412.42 (+3.1%)
SMA 200399.98 (+6.3%)
Beta0.34
S&P 52W Chg14.58%
Avg Vol (30d)88.25K
Avg Vol (10d)62.44K
Technical Indicators
RSI (14)63.7
MACD1.7385
MACD Signal-0.4842
MACD Hist.+2.2227
BB Upper420.96 GBp
BB Middle404.52 GBp
BB Lower388.09 GBp
BB Width8.13%
ATR (14)13.05 GBp
Vol Ratio (20d)1.17x